MedPath

Nursing Management of Irritable Bowel Syndrome (IBS) 2008

Not Applicable
Completed
Conditions
Irritable Bowel Syndrome
Interventions
Behavioral: Usual Care (Control Group)
Behavioral: Comprehensive Self-Management (CSM)
Registration Number
NCT00907790
Lead Sponsor
University of Washington
Brief Summary

The aim of this study is test the efficacy of a comprehensive self-management therapy to decrease abdominal pain/discomfort and improve quality of life in patients with irritable bowel syndrome (IBS) compared to IBS patients receiving their usual care.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
92
Inclusion Criteria
  • Men and women must be: 18-70 years old, have had symptoms of Irritable Bowel Syndrome (IBS) at least 6 mo prior to their diagnosis, and have had their diagnosis for at least 6 months, and the diagnosis had to be made by a health care provider (e.g., internist, gastroenterologist, family, nurse practitioner, physician assistant).
  • In addition, the subjects must be experiencing IBS symptoms as described in the Rome-III criteria.161 That is recurrent abdominal pain or discomfort at least 3 days a mo in the last 3 mo associated with 2 or more of the following: improvement with defecation, onset associated with a change in frequency or form (appearance) of their stool.
  • Adults 50 or older must have a negative colonoscopy, sigmoidoscopy, abdominal ultrasonography, or barium enema.
  • Anyone with a "red flag" symptom (e.g., lost 10 lbs without trying, blood in stool, anemia) will be contacted for additional clarification.
Read More
Exclusion Criteria
  • Participants will be excluded if they are taking the following medications: antibiotics, daily use of anticholinergics, tricyclic antidepressants, calcium-channel blockers
  • Have a medical history of abdominal surgery (except appendectomy, Caesarian section, tubal ligation, laparoscopic cholecystectomy, hysterectomy, or abdominal wall hernia repair)
  • Active organic GI disease, gluten intolerance (celiac disease), or chronic moderate to severe pain condition (e.g., low back pain, fibromyalgia)
  • Recent travel to regions with endemic parasitic diseases
  • Current mental health disorders (psychosis, bipolar disorder, current moderate to severe depressive episode, suicide attempt, drug or alcohol abuse or dependence within 2yrs)
  • Cardiac valvular disease, immune compromised immunologic disorders (e.g., autoimmune conditions)
  • Women who are pregnant, breast feeding, or planning to get pregnant in the next year
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual Care (Control Group)Usual Care (Control Group)Includes the usual care provided by the person and their health care provider.
Comprehensive Self-Management (CSM)Comprehensive Self-Management (CSM)Comprehensive Self-Management includes 8 sessions that cover education, diet, relaxation training, and cognitive behavioral strategies as they related to symptoms of IBS --------------------------------------------------------------------------------
Primary Outcome Measures
NameTimeMethod
Daily abdominal painBaseline, three and six months post randomization
IBS Quality of Life QuestionnaireBaseline, three and six months post randomization
Secondary Outcome Measures
NameTimeMethod
Salivary cortisolBaseline, three and six months post randomization
Interleukin-10(IL-10) and Interleukin-12(IL-12)Baseline, three and six months post randomization
Fecal calprotectinBaseline, three and six months post randomization
Intestinal permeability (urine)Baseline, three and six months post randomization
Brief Symptom InventoryBaseline, three and six months post randomization
Cognitive Scale for Functional Bowel DisordersBaseline three and six months post randomization
Work Productivity & Activity ImpairmentBaseline, three and six months post rand
Daily symptoms(other GI and psychological)Baseline, three and six months post randomization

Trial Locations

Locations (1)

University of Washington

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath